These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5592456)

  • 1. [Direct stilbamidine effect on the morphology and kinetics of plasmacytoma and myelopoietic cells].
    Boll I; Schuldt E; Sterzel RB
    Klin Wochenschr; 1967 Nov; 45(22):1131-5. PubMed ID: 5592456
    [No Abstract]   [Full Text] [Related]  

  • 2. Ultrastructural studies on human myeloma plasmacytes.
    Smetana K; Gyorkey F; Gyorkey P; Busch H
    Cancer Res; 1973 Oct; 33(10):2300-9. PubMed ID: 4741931
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma cell dyscrasias.
    Buss DH; Prichard RW; Cooper MR
    Hematol Oncol Clin North Am; 1988 Dec; 2(4):603-15. PubMed ID: 3065321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow changes following chemotherapy for multiple myeloma--a clinicopathological study of biopsy cases.
    Kurihara K; Hill W; Burkhardt R; Kettner G; Hashimoto N
    Nihon Ketsueki Gakkai Zasshi; 1987 Jul; 50(4):876-89. PubMed ID: 3687331
    [No Abstract]   [Full Text] [Related]  

  • 5. Early changes in bone marrow morphology induced by thalidomide in refractory myeloma patients.
    Corso A; Lorenzi A; Zappasodi P; Invernizzi R; Vanelli L; Lazzarino M
    Haematologica; 2003 Aug; 88(8):958-60. PubMed ID: 12935985
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bone marrow necrosis disclosing multiple myeloma of bone].
    Troussard X; Charpentier F; Haioun C; Cordonnier C; Vernant JP; Rochant H
    Presse Med; 1985 Oct; 14(36):1888. PubMed ID: 2933688
    [No Abstract]   [Full Text] [Related]  

  • 7. STILBAMIDINE In multiple myeloma.
    Am Prof Pharm; 1948 Aug; 14(8):705. PubMed ID: 18876607
    [No Abstract]   [Full Text] [Related]  

  • 8. Histological grading and clinical staging of plasmacytoma.
    Hokamp HG; Grundmann E
    J Cancer Res Clin Oncol; 1983; 105(2):197-8. PubMed ID: 6826641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the influence of stilbamidine upon multiple myeloma.
    SNAPPER I
    J Mt Sinai Hosp N Y; 1946; 13():119-27. PubMed ID: 20999714
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasmacytoma. Treatment results and conversion to myeloma.
    Holland J; Trenkner DA; Wasserman TH; Fineberg B
    Cancer; 1992 Mar; 69(6):1513-7. PubMed ID: 1540888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red-yellow marrow conversion: its effect on the location of some solitary bone lesions.
    Kricun ME
    Skeletal Radiol; 1985; 14(1):10-9. PubMed ID: 3895447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stilbamidine and pentamidine in multiple myeloma.
    SNAPPER I
    J Am Med Assoc; 1947 Jan; 133(3):157-61. PubMed ID: 20278624
    [No Abstract]   [Full Text] [Related]  

  • 13. [Electron microscopic studies on the effect of stilbamidine on plasmacytoma cells].
    Keyserlingk DG; Boll I
    Klin Wochenschr; 1969 Feb; 47(4):197-201. PubMed ID: 5369570
    [No Abstract]   [Full Text] [Related]  

  • 14. [Stilbamidine therapy of generalized plasmocytoma].
    GOLDECK H
    Klin Wochenschr; 1950 Jun; 28(23-24):399-401. PubMed ID: 15437815
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of treatment with APD-bisphosphonate on the bone lesions in the mouse 5T2 multiple myeloma.
    Radl J; Croese JW; Zurcher C; van den Enden-Vieveen MH; Brondijk RJ; Kazil M; Haaijman JJ; Reitsma PH; Bijvoet OL
    Cancer; 1985 Mar; 55(5):1030-40. PubMed ID: 3967188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of plasmacytoma in muscle as a complication of needle tract seeding after percutaneous bone marrow biopsy.
    Kansara G; Hussain M; Dimauro J
    Am J Clin Pathol; 1989 May; 91(5):604-6. PubMed ID: 2718961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of stilbamidine in multiple myeloma with pre-existing renal involvement; case report.
    MARKHAM JD; KRIZ JR; WILLIAMS JP
    Va Med Mon (1918); 1949 Jul; 76(7):347-55. PubMed ID: 18152688
    [No Abstract]   [Full Text] [Related]  

  • 18. A further note on the ultrastructure of myeloma plasmacytes.
    Smetana K; Hermanský F; Koblízková H; Pospísil V
    Neoplasma; 1971; 18(1):3-13. PubMed ID: 4324994
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin?
    Marchica V; Accardi F; Storti P; Mancini C; Martella E; Dalla Palma B; Bolzoni M; Todoerti K; Marcatti M; Schifano C; Bonomini S; Sammarelli G; Neri A; Ponzoni M; Aversa F; Giuliani N
    Int J Hematol; 2017 Jan; 105(1):104-108. PubMed ID: 27699576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of Kahler's disease with stilbamidine].
    SCHOONHOVEN VAN BEURDEN AJ
    Ned Tijdschr Geneeskd; 1950 May; 94(19):1345-51. PubMed ID: 15429918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.